Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements.
Kuypers
Dirk R J
DR
Bammens
Bert
B
Claes
Kathleen
K
Evenepoel
Pieter
P
Vanrenterghem
Yves
Y
D019540:Area Under Curve; D001739:BK Virus / Q000472:pathogenicity*; D016022:Case-Control Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D027601:Polyomavirus Infections / Q000453:epidemiology*; D012307:Risk Factors; D016559:Tacrolimus / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D014779:Virus Replication / Q000187:drug effects
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus